Skip to Main Content

Paper Details

Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302.
Eur J Cancer
11
2022
Author NameAffiliation
Johann S de BonoThe Institute of Cancer Research and Royal Marsden Hospital
Cora N SternbergEnglander Institute for Precision Medicine
Howard I ScherMemorial Sloan-Kettering Cancer Center
Dana E RathkopfMemorial Sloan Kettering Cancer Center
Kim N Chi
Fred SaadUniversity of Montreal Hospital Center
Anthony M JoshuaPrincess Margaret Cancer Centre, University of New South Wales, Australia Kinghorn Cancer Centre, St Vincents Hospital
  • 1 - 7

Datasets

Release 1.2